Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab + Chlorambucil in Japanese CLL
NCT01563055Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2012
- Primary completion
- Nov 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by GSK. Started Apr 2012; status: completed.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01563055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563055.